02-031 C.M.R. ch. 490, § 3 - Definitions
A. "Informed Consent" means consent to
testing for the presence of antibodies to the Human Immunodeficiency Virus or
for the presence of the Human Immunodeficiency Antigen. The Informed Consent
shall be based on an actual understanding by the person to be tested:
1. That the test is being
performed;
2. Of the nature of the
test;
3. Of the persons to whom the
results of that test may be disclosed;
4. Of the purpose for which the test results
may be used; and
5. Of any
reasonably foreseeable risks and benefits resulting from the test.
The informed consent shall be wholly voluntarily and free from express or implied coercion.
B. "Antibodies" to HIV means the specific
immunoglobulin produced by the body's immune system in response to
HIV.
C. "HIV" means the Human
Immunodeficiency Virus identified as the causative agent of Acquired Immune
Deficiency Syndrome or AIDS.
D.
"HIV Antigen" means the specific immune-recognizable marker protein of
HIV.
E. "HIV Infection" means the
state where HIV invades the body and is believed to be present in the body as
indicated by a repeatedly positive enzyme immunoassay (EIA), and confirmed by a
positive Western Blot immunofluorescence assay, or other generally accepted
secondary level testing.
F. "HIV
Test" means a test which tests for the presence of the antibody to HIV or a
test for an HIV antigen.
G.
"Nonprofit Entity" means a nonprofit hospital or medical service organization
or a nonprofit health care plan.
H.
"Post-Test Counseling" for persons required to take an HIV test by an insurer,
nonprofit hospital or medical service organization, or health care plan shall
be defined pursuant to
5 M.R.S.A.
§19204-A.
I. "Superintendent" means Superintendent of
Insurance.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.